Galen Growth is pleased to share with you our 2024 Global Analysis on Digital Health Funding, Key Trends and Innovation. We look across the global startup ecosystem for Digital Health and explain the current trends that are driving demand. Our analysis focuses on private ventures and includes ecosystem growth, most active partners, regulatory approvals and venture funding.
This report, powered by HealthTech Alpha- a Galen Growth proprietary solution and the world’s leading Digital Health private market data, intel, and insights platform- offers unmatched, non-biased, non-hyped, and data-driven coverage of the global Digital Health ecosystems.
The 2024 Global Analysis on Digital Health Funding, Key Trends, and Innovation is a must-read for stakeholders navigating the rapidly evolving healthcare landscape. Here’s why this report is critical:
The “Digital Health 2024 Funding and Key Trends” report includes data on the following companies: Sword Health, Xaira Therapeutics, Included Health, Hinge Health, Medable, Aledade, Spring Health, Omada Health, Virta Health, Cityblock Health, Color Health, Lyra Health, Oura, Innovaccer, Fabric, Soda Health, Infinitus, HealthifyMe, Freya Biosciences, Centaur Labs, SandboxAQ, Freenome, Alan, Kestra Medical Technologies, Foodsmart, Blackrock Neurotech, Flo Health, AstraZeneca, Daiichi Sankyo, Italfarmaco, Samsung Life Insurance, NVIDIA, Mayo Clinic, Lilly, Pfizer, Roche, Novo Nordisk, Sanofi, General Catalyst, Andreessen Horowitz, Khosla Ventures, Bill & Melinda Gates Foundation, Alumni Ventures
This report is powered by HealthTech Alpha, the premier digital health intelligence platform delivering unparalleled data and insights into the evolving healthcare technology landscape. By leveraging its extensive database of over 14,000 ventures and cutting-edge analytics, HealthTech Alpha provides a data-driven foundation to analyze the critical trends and innovations shaping the future of medtech.
Designed to empower stakeholders—including investors, pharmaceutical leaders, and medical device manufacturers—HealthTech Alpha offers actionable intelligence to navigate the complexities of digital transformation in healthcare. This collaboration brings readers a comprehensive view of the intersection between digital health and medtech, equipping them with the insights needed to identify opportunities, assess market dynamics, and make strategic decisions in this rapidly advancing industry.
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.
Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com
Pages | Description | Content |
---|---|---|
– | Key Insights | – |
12 – 28 | Digital Health Resilience, Recovery, and the Road Ahead | 18 charts, 5 tables |
29 – 36 | Ecosystem Insights | 10 charts, 3 tables |
37 – 50 | Investment Insights | 34 charts, 3 tables |
51 – 57 | Cluster Focus | 4 charts, 2 tables |
58 – 61 | Therapeutic Focus | 3 charts, 1 table |
62 – 80 | Regional Snapshots | 20 charts, 4 tables |
– | Key Information | – |